Regenxbio Inc. (RGNX) PT Raised to $45 at Stifel: Lead Programs Have 2026 Catalysts
Tweet Send to a Friend
Stifel analyst Annabel Samimy raised the price target on Regenxbio Inc. (NASDAQ: RGNX) to $45.00 (from $40.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
